// App-Quantinova.ai

: Twelve month outcomes with Reslizumab treatment of Eosinophilic Granulomatosis with Polyangiitis

Researchers

Presenter

  • Brian Kent

Principal Investigators

  • Grainne DAncona

  • Mariana Fernandes

  • Linda Green

  • Joanna Kavanagh

  • Alexandra Nanzer-Kelly

  • Cris Roxas

  • Sangita Agarwal

  • David Jackson

Medical Centers

  • Guy's Severe Asthma Centre, Guy's & St Thomas' Hospitals, London, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Eosinophilic granulomatosis with polyangiitis

  • Asthma

  • Spastic paraplegia, intellectual disability, nystagmus, and obesity

Biomarkers

  • Cancer antigen 15-3

Drug/Treatment

  • Prednisolone

  • Mepolizumab

  • Reslizumab

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved